These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 6136893
21. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action. Gutniak M, Grill V, Efendić S. J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196 [Abstract] [Full Text] [Related]
22. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B. Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [Abstract] [Full Text] [Related]
23. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus. Burge MR, Waters DL, Holcombe JH, Schade DS. J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507 [Abstract] [Full Text] [Related]
24. Clinical evaluation of somatostatin as a potential ajunct to insulin in the management of diabetes mellitus. Gerich JE, Schultz TA, Lewis SB, Karam JH. Diabetologia; 1977 Sep; 13(5):537-44. PubMed ID: 908478 [Abstract] [Full Text] [Related]
25. Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study. Riddle MC, Nahra R, Han J, Castle J, Hanavan K, Hompesch M, Huffman D, Strange P, Öhman P. Diabetes Care; 2018 Nov; 41(11):2346-2352. PubMed ID: 30213882 [Abstract] [Full Text] [Related]
31. Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes. Underland LJ, Ilkowitz JT, Katikaneni R, Dowd A, Heptulla RA. J Diabetes Sci Technol; 2017 May; 11(3):602-610. PubMed ID: 28349708 [Abstract] [Full Text] [Related]
32. Acute effect of the somatostatin analogue SMS-201995 on plasma glucose and triglycerides in insulin-dependent diabetic patients. Malerbi DA, de-Camargo JW, Cesar FP, Wajchenberg BL. Braz J Med Biol Res; 1992 May; 25(6):593-600. PubMed ID: 1342235 [Abstract] [Full Text] [Related]
35. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. Gutniak M, Orskov C, Holst JJ, Ahrén B, Efendic S. N Engl J Med; 1992 May 14; 326(20):1316-22. PubMed ID: 1348845 [Abstract] [Full Text] [Related]
36. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB. Diabetes Care; 1995 Nov 14; 18(11):1452-9. PubMed ID: 8722069 [Abstract] [Full Text] [Related]